Photo taken from Tia Cheunkarndee/LinkedIn
May 20, 2024, 08:02
Tia Cheunkarndee: Our work on first line osimertinib for uncommon ex19del and compound EGFRm in NSCLC!
Tia Cheunkarndee, Medical Student at the Johns Hopkins University School of Medicine, shared a post on LinkedIn:
“So excited to share our work on 1L osimertinib for uncommon ex19del and compound EGFRm in NSCLC! Huge thanks to Susan Scott, Kristen A. Marrone, Matthew Guo, Johns Hopkins Thoracic Oncology for their mentorship on this project.”
